Long-term study supports tenofovir alafenamide for chronic hepatitis B

Long-term study supports tenofovir alafenamide for chronic hepatitis B

Summary

Tenofovir alafenamide (TAF) has demonstrated comparable efficacy to tenofovir disoproxil fumarate (TDF), with improved renal and bone safety, in Chinese partici...

Description

Tenofovir alafenamide (TAF) has demonstrated comparable efficacy to tenofovir disoproxil fumarate (TDF), with improved renal and bone safety, in Chinese partici...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Open original source